The Biotech Bargain: How Patents Help Turn Risk Into Medicine
Do patents make drugs more expensive? And what role does intellectual property play in getting new medicines from the lab bench to patients? The questions have never been more timely. Biopharmaceutical innovation sits at the center of some of our biggest public policy debates. Drug pricing, access, generic competition, university research, venture funding, AI-driven discovery, follow-on research, and the future of biotech startups. And in the middle of those debates, patents are often reduce...